Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 1666 AL 1680

Value of blood neural cell-derived small extracellular vesicles in the diagnosis and prediction of Alzheimer's disease: A systematic review

Pan W, Teng Y, Han X, Liu S, Pang X, Wang L, Zhao M.

J Prev Alzheimers Dis. 2025 Aug;12(7):100193. doi: 10.1016/j.tjpad.2025.100193. Epub 2025 May 1.

Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group

Ng TKS, Udeh-Momoh C, Lim MA, Gleerup HS, Leifert W, Ajalo C, Ashton N, Zetterberg H, Rissman RA, Winston CN, O' Bryant S, Jenkins R, Carro E, Orive G, Tamburin S, Olvera-Rojas M, Solis-Urra P, Esteban-Cornejo I, Santos GAAD, Rajan KB, Koh D, Simonsen AH, Slowey PD; Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment: Biofluid Based Biomarkers Professional Interest Area Salivary Biomarkers for Dementia Research Working Group (ISTAART‐BBB‐PIA‐SWG).

Alzheimers Dement. 2025 Feb;21(2):e14420. doi: 10.1002/alz.14420. Epub 2024 Dec 30.

Neuron-derived extracellular vesicles as a liquid biopsy for brain insulin dysregulation in Alzheimer's disease and related disorders

Cleary JA, Kumar A, Craft S, Deep G.

Alzheimers Dement. 2025 Feb;21(2):e14497. doi: 10.1002/alz.14497. Epub 2025 Jan 17.

Retinal and Vascular Findings in Optical Coherence Tomography in Healthy Cognitive Patients With Alzheimer Disease Biomarkers: A Systematic Review and Meta-Analysis

Leal-Bernal C, Noriega-Ramírez S, Álvarez-Martínez JV, Cifuentes-González C, Rojas-Carabali W, Manrique-Samer A, Flórez-Esparza V, Monsalve-García I, Amézquita-Villanueva JS, Mejía-Salgado G, Nava-Mesa MO, de-la-Torre A.

Alzheimer Dis Assoc Disord. 2025 Apr-Jun 01;39(2):140-149. doi: 10.1097/WAD.0000000000000669. Epub 2025 May 13.

Association of dipeptidyl peptidase-4 with Alzheimer's disease: A new therapeutic prospect

Wang X, Chen L, Li W, He Z, Jiang H.

J Alzheimers Dis. 2025 Jan;103(2):319-332. doi: 10.1177/13872877241304673. Epub 2025 Jan 8.

Sex-specific associations of neurodegeneration and inflammatory biomarkers with intrinsic capacity in older adults: Findings from the 4-year longitudinal Multidomain Alzheimer's Prevention Trial (MAPT)

de Assunção Cortez Corrêa LC, Raffin J, Vellas B, Guerra RO, de Souto Barreto P.

Maturitas. 2025 Feb;193:108191. doi: 10.1016/j.maturitas.2024.108191. Epub 2025 Jan 3.

Extracellular vesicle-packed microRNAs profiling in Alzheimer's disease: The molecular intermediary between pathology and diagnosis

Arif S, Qazi TJ, Quan Z, Ni J, Li Z, Qiu Y, Qing H.

Ageing Res Rev. 2025 Feb;104:102614. doi: 10.1016/j.arr.2024.102614. Epub 2024 Dec 1.

Signaling Molecules and Diagnosis of Cognitive Disorders: Current State and Prospects

Kvetnoy I, Kheyfets O, Safaniev L, Kheifets V, Mironova E, Kvetnaia T, Mazzoccoli G, Prashchayeu K, Gavrilova A.

Int J Mol Sci. 2025 Dec 29;27(1):372. doi: 10.3390/ijms27010372.

[A new look at blood biomarkers in Alzheimer's patients]

Bogolepova AN, Kovalenko EA, Gileva EA, Makhnovich EV, Gasilova AD, Skvortsov DI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2025;125(12):7-13. doi: 10.17116/jnevro20251251217.

Disclosure of plasma p-tau217 measure improves diagnostic confidence in patients with Alzheimer's disease versus syndromes associated with frontotemporal lobar degeneration

Cantoni V, Cotelli MS, Rota M, Alberici A, Libri I, Huber H, Tan K, Ghidoni R, Bellini S, Zetterberg H, Blennow K, Ashton NJ, Borroni B.

Alzheimers Dement. 2025 May;21(5):e70289. doi: 10.1002/alz.70289.

Blood-based biomarkers for Alzheimer's disease: positioning document and usage recommendations from the Behavioral Neurology and Dementia Study Group of the Spanish Society of Neurology

Suárez-Calvet M, Abdelnour C, Alcolea D, Mendióroz-Iriarte M, Balasa M, Morenas-Rodríguez E, Puig-Pijoan A, Sánchez-Juan P, Villarejo A, Sánchez-Valle R; por el Grupo de trabajo en biomarcadores en sangre del Grupo de Estudio de Conducta y Demencias de la Sociedad Española de Neurología.

Neurologia (Engl Ed). 2025 Sep;40(7):700-712. doi: 10.1016/j.nrleng.2025.07.004. Epub 2025 Jul 18.

Amyloid-β Clearance with Monoclonal Antibodies: Transforming Alzheimer's Treatment

Fatima R, Khan Y, Maqbool M, Ramalingam PS, Khan MG, Bisht AS, Hussain MS.

Curr Protein Pept Sci. 2025;26(7):515-545. doi: 10.2174/0113892037362037250205143911.

Treatment-related amyloid clearance (TRAC): a framework to characterize patients in the era of anti-amyloid therapies

La Joie R, Cummings JL, Dage JL, Galasko D, Ikonomovic MD, Karikari TK, Landau SM, Llibre-Guerra JJ, Mummery CJ, Ossenkoppele R, Price JC, Risacher SL, Smith R, van Dyck CH, Carrillo MC.

Alzheimers Dement. 2025 Nov;21(11):e70997. doi: 10.1002/alz.70997.

Blood-Based Tau as a Biomarker for Early Detection and Monitoring of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kim KY, Shin KY, Chang KA.

Int J Mol Sci. 2025 Oct 23;26(21):10330. doi: 10.3390/ijms262110330.

Comparing high and low amyloid producers in Alzheimer's disease: An in-depth analysis

Leroy M, Aziz AL, Schraen S, Deramecourt V, Skrobala E, Lecerf S, Pasquier F, Huin V, Bertoux M, Lebouvier T.

Rev Neurol (Paris). 2025 Apr;181(4):332-341. doi: 10.1016/j.neurol.2025.02.004. Epub 2025 Mar 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias